A clinical trial to test the safety and effectiveness of a new drug, tefinostat, for patients with chronic myelomonocytic leukaemia

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-002281-23

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

1. Is tefinostat (CHR-2845) safe and tolerable for patients with CMML? 2. Is tefinostat clinically effective in CMML? (primary efficacy endpoint will be overall clinical response rate according to the International Consortium MDS/MPN Response Criteria).


Critère d'inclusion

  • Chronic myelomonocytic leukaemia (CMML)